Greater Celandine (Chelidonium majus)

Greater celandine (Chelidonium majus) is a European herb containing isoquinoline alkaloids like chelidonine and sanguinarine that demonstrate antioxidant and cytotoxic properties. The plant's bioactive compounds work through enzyme inhibition mechanisms, particularly affecting cholinesterase and tyrosinase activity.

Origin & History

Greater celandine (Chelidonium majus) is a perennial herb in the Papaveraceae family, native to Europe and western Asia, now naturalized globally. The plant's aerial parts and roots are extracted using solvents like methanol or water to yield alkaloid-rich fractions containing over 70 identified compounds, predominantly isoquinoline alkaloids.

Historical & Cultural Context

Greater celandine has been used in European traditional medicine since the 1st century CE, documented by Pliny the Elder and Dioscorides for skin ailments, warts, and digestive issues. The plant features in global herbal traditions for its distinctive yellow latex and alkaloid properties.

Health Benefits

• Antioxidant activity demonstrated in vitro through high phenolic content in methanol extracts (preliminary evidence only)
• Enzyme inhibition showing cholinesterase and tyrosinase inhibitory effects in laboratory studies (in vitro evidence)
• Selective cytotoxicity against cancer cell lines HGC-27 and HT-29 without harming non-cancerous HEK293 cells (preliminary in vitro data)
• Antimicrobial activity via membrane-lytic peptide CM-AMP1 against E. coli (laboratory evidence only)
• Traditional use for skin conditions and digestive issues dating to 1st century CE (historical evidence only)

How It Works

Greater celandine's isoquinoline alkaloids, particularly chelidonine and sanguinarine, exert biological effects through enzyme inhibition pathways. The herb demonstrates cholinesterase inhibitory activity, which affects acetylcholine metabolism, and tyrosinase inhibition, which impacts melanin synthesis. Its phenolic compounds contribute to antioxidant activity by scavenging free radicals and reducing oxidative stress.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified in the research dossier. Current evidence consists solely of in vitro studies showing antioxidant, enzyme inhibitory, and selective cytotoxic effects, plus antimicrobial peptide characterization studies.

Clinical Summary

Current evidence for greater celandine is limited to in vitro laboratory studies rather than human clinical trials. Research has demonstrated antioxidant activity through high phenolic content in methanol extracts, though this represents only preliminary evidence. Laboratory studies show enzyme inhibition effects against cholinesterase and tyrosinase, and selective cytotoxicity against HGC-27 cancer cell lines. Human studies with specific dosages and clinical outcomes are lacking, limiting the strength of therapeutic claims.

Nutritional Profile

Greater Celandine (Chelidonium majus) is not consumed as a food ingredient due to its toxicity, so conventional macronutrient profiling is not applicable in a dietary sense. However, its phytochemical and bioactive compound profile is well-characterized. Primary bioactive constituents include isoquinoline alkaloids at approximately 0.1–1.0% dry weight of aerial parts, with the dominant alkaloids being chelidonine (0.2–0.4% dry weight), coptisine, berberine (0.08–0.2% dry weight), sanguinarine (0.02–0.1% dry weight), chelerythrine (0.04–0.2% dry weight), and sparteine in trace amounts. Phenolic compounds are present at approximately 15–45 mg gallic acid equivalents per gram of methanol extract, including flavonoids such as rutin and quercetin derivatives, hydroxycinnamic acids (caffeic and chlorogenic acid), and tannins. Carotenoids, including beta-carotene and lutein, are present in the yellow-orange latex. Chelidonic acid (a pyranone dicarboxylic acid) is a characteristic compound at approximately 0.1–0.3% dry weight. Proteolytic enzymes (cysteine proteases) are present in the latex. Essential oils constitute less than 0.01% of aerial parts. Bioavailability data is limited; alkaloid absorption in humans is documented via hepatic metabolism studies but precise bioavailability percentages are not established. No significant dietary fiber, protein, or conventional micronutrient data is reported, as the plant is used medicinally in very small doses, not nutritionally.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials have not been conducted. Traditional preparations use aerial parts (0.27-2.25% alkaloids) or roots (3-4% alkaloids) in various solvent extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk Thistle, Dandelion Root, Turmeric, Artichoke Leaf, Schisandra

Safety & Interactions

Greater celandine contains potentially hepatotoxic alkaloids and has been associated with liver damage in case reports. The herb may interact with medications metabolized by the liver and could potentiate effects of cholinesterase inhibitors used in dementia treatment. Pregnant and breastfeeding women should avoid use due to alkaloid content and potential toxicity. Individuals with liver disease or taking hepatotoxic medications should exercise particular caution.